Genpact (G) Initiated with Outperform Rating at Oppenheimer

Genpact (G) has been initiated today with a Outperform rating by the research analysts at Oppenheimer.  The firm has also placed a price target of $20 dollars on the company.

The company is currently trading above its 50 & 200-day moving averages.  The yearly high for Genpact is $18.71 with the low being $13.09 per share.  Gentech has a market cap of $3,584,000,000 with 221,150,000 shares outstanding.  The company is trading at an overall gain for 2011.

Genpact (G) a global leader in business process and technology management, offering a broad portfolio of enterprise and industry-specific services. We manage over 3,000 processes for more than 400 clients worldwide.

Latest News

The Manufacturers Life Insurance Company Sells 590,321 Shares of DowDuPont Inc
The Manufacturers Life Insurance Company Sells 590,321 Shares of DowDuPont Inc
CannabisCoin  Price Reaches $0.0049 on Top Exchanges
CannabisCoin Price Reaches $0.0049 on Top Exchanges
Shadow Token  Achieves Market Cap of $84,839.00
Shadow Token Achieves Market Cap of $84,839.00
Axovant Sciences Ltd  Shares Sold by Virtus ETF Advisers LLC
Axovant Sciences Ltd Shares Sold by Virtus ETF Advisers LLC
Virtus ETF Advisers LLC Sells 1,710 Shares of bluebird bio Inc
Virtus ETF Advisers LLC Sells 1,710 Shares of bluebird bio Inc
Alnylam Pharmaceuticals, Inc.  Shares Sold by Virtus ETF Advisers LLC
Alnylam Pharmaceuticals, Inc. Shares Sold by Virtus ETF Advisers LLC


© 2006-2018 Ticker Report